
Wei Wu He
Description
Dr. He has been serving as Executive Chairman of Human Longevity Inc since July 2019. Prior to HLI, Dr. He was the CEO of OriGene Technologi...
Investor Profile
Wei Wu He has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Medical, Pharmaceutical.
Stage Focus
- Post Ipo Equity (100%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Medical
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.